EIR Novartis Pharmaceuticals Sep 2017

Peter Lenahan FDA, Nina Yang FDA$595.00 - Available Now

FDA investigators audited the Novartis Pharmaceuticals - East Hanover, NJ, United States facility and issued inspectional observation (via FDA 483) on 07 Sep 2017.

Product details

  • Category:
  • Inspection end: 07 Sep 2017
  • Location: East Hanover, United States
  • FEI: 2210396
Add To Cart